SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Additionally, pharmacological agents such as fenfluramine, stiripentol, and cannabidiol, although not acting directly on sodium channels, represent recognized therapeutic options for SCN1A-related Dravet syndrome.